ID: ALA4635078

Max Phase: Preclinical

Molecular Formula: C16H13N3O2

Molecular Weight: 279.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cccc(-n2cc(-c3ccccc3)nn2)c1

Standard InChI:  InChI=1S/C16H13N3O2/c1-21-16(20)13-8-5-9-14(10-13)19-11-15(17-18-19)12-6-3-2-4-7-12/h2-11H,1H3

Standard InChI Key:  ZMVNUBPBCUFKMA-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.30Molecular Weight (Monoisotopic): 279.1008AlogP: 2.72#Rotatable Bonds: 3
Polar Surface Area: 57.01Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.71CX LogD: 3.71
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.69Np Likeness Score: -1.70

References

1. Kronenberger T, Ferreira GM, de Souza ADF, da Silva Santos S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise-Filho R..  (2020)  Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors.,  28  (15): [PMID:32631571] [10.1016/j.bmc.2020.115600]

Source